Differences in interactions between transmembrane domains tune the activation of metabotropic glutamate receptors

  1. Jordana K Thibado
  2. Jean-Yves Tano
  3. Joon Lee
  4. Leslie Salas-Estrada
  5. Davide Provasi
  6. Alexa Strauss
  7. Joao Marcelo Lamim Ribeiro
  8. Guoqing Xiang
  9. Johannes Broichhagen
  10. Marta Filizola
  11. Martin J Lohse
  12. Joshua Levitz  Is a corresponding author
  1. Weill Cornell Graduate School of Medical Sciences, United States
  2. Max Delbrück Center for Molecular Medicine, Germany
  3. Weill Cornell Medicine, United States
  4. Icahn School of Medicine at Mount Sinai, United States
  5. Forschungsinstitut für Molekulare Pharmakologie, Germany

Abstract

The metabotropic glutamate receptors (mGluRs) form a family of neuromodulatory G protein-coupled receptors that contain both a seven-helix transmembrane domain (TMD) and a large extracellular ligand-binding domain (LBD) which enables stable dimerization. While numerous studies have revealed variability across subtypes in the initial activation steps at the level of LBD dimers, an understanding of inter-TMD interaction and rearrangement remains limited. Here we use a combination of single molecule fluorescence, molecular dynamics, functional assays, and conformational sensors to reveal that distinct TMD assembly properties drive differences between mGluR subtypes. We uncover a variable region within transmembrane helix 4 (TM4) that contributes to homo- and heterodimerization in a subtype-specific manner and tunes orthosteric, allosteric and basal activation. We also confirm a critical role for a conserved inter-TM6 interface in stabilizing the active state during orthosteric or allosteric activation. Together this study shows that inter-TMD assembly and dynamic rearrangement drive mGluR function with distinct properties between subtypes.

Data availability

We have provided source data files for all relevant figures.

Article and author information

Author details

  1. Jordana K Thibado

    Physiology, Biophysics and Systems Biology Graduate Program, Weill Cornell Graduate School of Medical Sciences, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Jean-Yves Tano

    Receptor Signaling Lab, Max Delbrück Center for Molecular Medicine, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Joon Lee

    Department of Biochemistry, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Leslie Salas-Estrada

    Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Davide Provasi

    Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2868-303X
  6. Alexa Strauss

    Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Joao Marcelo Lamim Ribeiro

    Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Guoqing Xiang

    Department of Biochemistry, Weill Cornell Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Johannes Broichhagen

    Department of Chemical Biology, Forschungsinstitut für Molekulare Pharmakologie, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3084-6595
  10. Marta Filizola

    Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Martin J Lohse

    Receptor Signaling Lab, Max Delbrück Center for Molecular Medicine, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Joshua Levitz

    Department of Biochemistry, Weill Cornell Medicine, New York, United States
    For correspondence
    jtl2003@med.cornell.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8169-6323

Funding

National Institute of General Medical Sciences (R35 GM124731)

  • Joshua Levitz

National Science Foundation (GRFP)

  • Jordana K Thibado

National Institute on Drug Abuse (DA038882)

  • Marta Filizola

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Janice L Robertson, Washington University in St Louis, United States

Version history

  1. Received: January 29, 2021
  2. Accepted: April 19, 2021
  3. Accepted Manuscript published: April 21, 2021 (version 1)
  4. Version of Record published: May 6, 2021 (version 2)

Copyright

© 2021, Thibado et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,977
    views
  • 297
    downloads
  • 20
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jordana K Thibado
  2. Jean-Yves Tano
  3. Joon Lee
  4. Leslie Salas-Estrada
  5. Davide Provasi
  6. Alexa Strauss
  7. Joao Marcelo Lamim Ribeiro
  8. Guoqing Xiang
  9. Johannes Broichhagen
  10. Marta Filizola
  11. Martin J Lohse
  12. Joshua Levitz
(2021)
Differences in interactions between transmembrane domains tune the activation of metabotropic glutamate receptors
eLife 10:e67027.
https://doi.org/10.7554/eLife.67027

Share this article

https://doi.org/10.7554/eLife.67027

Further reading

    1. Neuroscience
    2. Stem Cells and Regenerative Medicine
    Pascal Forcella, Niklas Ifflander ... Verdon Taylor
    Research Article

    Neural stem cells (NSCs) are multipotent and correct fate determination is crucial to guarantee brain formation and homeostasis. How NSCs are instructed to generate neuronal or glial progeny is not well understood. Here we addressed how murine adult hippocampal NSC fate is regulated and describe how Scaffold Attachment Factor B (SAFB) blocks oligodendrocyte production to enable neuron generation. We found that SAFB prevents NSC expression of the transcription factor Nuclear Factor I/B (NFIB) by binding to sequences in the Nfib mRNA and enhancing Drosha-dependent cleavage of the transcripts. We show that increasing SAFB expression prevents oligodendrocyte production by multipotent adult NSCs, and conditional deletion of Safb increases NFIB expression and oligodendrocyte formation in the adult hippocampus. Our results provide novel insights into a mechanism that controls Drosha functions for selective regulation of NSC fate by modulating the post-transcriptional destabilization of Nfib mRNA in a lineage-specific manner.

    1. Neuroscience
    Paula Banca, Maria Herrojo Ruiz ... Trevor W Robbins
    Research Article

    This study investigates the goal/habit imbalance theory of compulsion in obsessive-compulsive disorder (OCD), which postulates enhanced habit formation, increased automaticity, and impaired goal/habit arbitration. It directly tests these hypotheses using newly developed behavioral tasks. First, OCD patients and healthy participants were trained daily for a month using a smartphone app to perform chunked action sequences. Despite similar procedural learning and attainment of habitual performance (measured by an objective automaticity criterion) by both groups, OCD patients self-reported higher subjective habitual tendencies via a recently developed questionnaire. Subsequently, in a re-evaluation task assessing choices between established automatic and novel goal-directed actions, both groups were sensitive to re-evaluation based on monetary feedback. However, OCD patients, especially those with higher compulsive symptoms and habitual tendencies, showed a clear preference for trained/habitual sequences when choices were based on physical effort, possibly due to their higher attributed intrinsic value. These patients also used the habit-training app more extensively and reported symptom relief post-study. The tendency to attribute higher intrinsic value to familiar actions may be a potential mechanism leading to compulsions and an important addition to the goal/habit imbalance hypothesis in OCD. We also highlight the potential of smartphone app training as a habit reversal therapeutic tool.